Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
5.68
-0.22 (-3.73%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Acelyrin Statistics

Total Valuation

Acelyrin has a market cap or net worth of $566.91 million. The enterprise value is -$45.06 million.

Market Cap 566.91M
Enterprise Value -45.06M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, after market close.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

Acelyrin has 99.81 million shares outstanding. The number of shares has increased by 337.21% in one year.

Shares Outstanding 99.81M
Shares Change (YoY) +337.21%
Shares Change (QoQ) +1.27%
Owned by Insiders (%) 3.88%
Owned by Institutions (%) 77.83%
Float 64.30M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.03
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.86, with a Debt / Equity ratio of 0.00.

Current Ratio 7.86
Quick Ratio 7.77
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -43.79% and return on invested capital (ROIC) is -38.61%.

Return on Equity (ROE) -43.79%
Return on Assets (ROA) -35.63%
Return on Capital (ROIC) -38.61%
Revenue Per Employee n/a
Profits Per Employee -$2.22M
Employee Count 135
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -46.43% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -46.43%
50-Day Moving Average 5.18
200-Day Moving Average 5.69
Relative Strength Index (RSI) 46.94
Average Volume (20 Days) 594,512

Short Selling Information

The latest short interest is 5.16 million, so 5.17% of the outstanding shares have been sold short.

Short Interest 5.16M
Short Previous Month 6.39M
Short % of Shares Out 5.17%
Short % of Float 8.03%
Short Ratio (days to cover) 5.84

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -423.82M
Pretax Income -240.16M
Net Income -299.80M
EBITDA -423.56M
EBIT -423.82M
Earnings Per Share (EPS) -$3.06
Full Income Statement

Balance Sheet

The company has $635.24 million in cash and $1.31 million in debt, giving a net cash position of $633.93 million or $6.35 per share.

Cash & Cash Equivalents 635.24M
Total Debt 1.31M
Net Cash 633.93M
Net Cash Per Share $6.35
Equity (Book Value) 568.22M
Book Value Per Share 5.71
Working Capital 565.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$216.33 million and capital expenditures -$1.16 million, giving a free cash flow of -$217.49 million.

Operating Cash Flow -216.33M
Capital Expenditures -1.16M
Free Cash Flow -217.49M
FCF Per Share -$2.18
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Acelyrin does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -337.21%
Shareholder Yield -337.21%
Earnings Yield -50.91%
FCF Yield -36.93%

Analyst Forecast

The average price target for Acelyrin is $11.17, which is 96.66% higher than the current price. The consensus rating is "Buy".

Price Target $11.17
Price Target Difference 96.66%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -61.09%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1